• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC CARTO VIZIGO¿ 8.5F BI-DIRECTIONAL GUIDING SHEATH; INTRODUCER, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC CARTO VIZIGO¿ 8.5F BI-DIRECTIONAL GUIDING SHEATH; INTRODUCER, CATHETER Back to Search Results
Catalog Number D138502
Device Problem Detachment of Device or Device Component (2907)
Patient Problem Blood Loss (2597)
Event Date 05/07/2019
Event Type  malfunction  
Manufacturer Narrative
On 5/24/2019, the biosense webster inc.(bwi) product analysis lab (pal) received the device for evaluation and found the brim cap broken with missing pieces.Additionally, the hemostatic valve and friction ring were missing.The additional findings of broken brim cap has been assessed as mdr reportable.The analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.On 5/14/2019, a manufacturing record evaluation was performed, and no internal actions were found during the review.Manufacture reference no: (b)(4).
 
Event Description
It was reported that a male patient underwent an atrial fibrillation (afib) ablation procedure on which a carto vizigo¿ 8.5f bi-directional guiding sheath was used, and hemostatic valve detachment occurred which resulted in blood leakage from the sheath.During the procedure, the hemostatic valve became detached from the vizigo sheath.While the catheter was in the body, there was minimum to no blood.However, after removing the catheter, there was blood leaking from the sheath.The vizigo sheath was replaced and the issue resolved.No medical intervention or surgical intervention was performed and extended hospitalization was not required.Patient¿s outcome was fully recovered with no residual effects.Physician¿s opinion regarding the cause of the bleeding event is that it was related to a bwi product malfunction.The observed blood loss has been assessed as not mdr reportable.The observed hemostatic valve separation has been assessed as an mdr reportable malfunction.
 
Manufacturer Narrative
It was reported that a male patient underwent an atrial fibrillation (afib) ablation procedure on which a carto vizigo¿ 8.5f bi-directional guiding sheath was used, and hemostatic valve detachment occurred which resulted in blood leakage from the sheath.The investigational analysis completed (b)(6)2019.The device was inspected, and the brim cap was found broken and some pieces were missing.The hemostatic valve and the friction ring were missing.A manufacturing record evaluation was performed, and no internal actions were identified.The customer complaint was confirmed.The root cause of the damage on brim cap cannot be determined.However, an internal corrective action was created to investigate this issue.Manufacture ref no:(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARTO VIZIGO¿ 8.5F BI-DIRECTIONAL GUIDING SHEATH
Type of Device
INTRODUCER, CATHETER
Manufacturer (Section D)
BIOSENSE WEBSTER INC
33 technology drive
irvine CA 92618
MDR Report Key8655703
MDR Text Key149000442
Report Number2029046-2019-03186
Device Sequence Number1
Product Code LPB
UDI-Device Identifier10846835016277
UDI-Public10846835016277
Combination Product (y/n)N
PMA/PMN Number
K170997
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 05/07/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/22/2019
Device Catalogue NumberD138502
Device Lot Number00001065
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/24/2019
Initial Date Manufacturer Received 05/07/2019
Initial Date FDA Received05/30/2019
Supplement Dates Manufacturer Received06/25/2019
Supplement Dates FDA Received07/03/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-